Ebiloma S, Uche OC, Okorie CN, Itubochi CO, Happiness E. Targeting the P53–Mdm2 Axis In Breast Cancer: Integrating Artificial Intelligence, Multi-Omics, and Natural Compounds to Overcome Therapeutic Resistance. TJPPS [Internet]. 2026 Sep. 16 [cited 2026 Sep. 16];5(5):611-20. Available from: https://tjpps.org/index.php/home/article/view/290